It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
International health organisations and experts say antiretroviral therapy and medication helps people living with HIV to live ...
Researchers have found a striking new way to potentially eliminate HIV soon after infection using a one-time combination of three therapies. In newborn nonhuman primates treated within three days of ...
For the past four decades, oral antiretroviral therapy for HIV has required daily doses. Long-acting injectable cabotegravir ...
A similar model of bringing testing into less engaged communities could potentially be implemented elsewhere with adequate funding, resources, and buy-in.
The introduction of harsh penalties for same-sex relations has created a climate of fear that is severely disrupting HIV services. Gilbert Nakweya reports.
Gilead's twice-yearly shot reduced HIV infections by 96% in a second large study, the company said. The data sets the stage for likely FDA approval of lenacapavir for HIV prevention. Shares rose 3% in ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new sequential immunization strategy shows strong promise for an HIV vaccine, a ...
HIV health providers have already absorbed some cuts and fear more. They worry that gains made toward eliminating the virus are in jeopardy. The post ‘We are living in reverse.’ Fragile HIV funding ...
ART iniitiation, managing comorbidities addressed for aging patients ...
For years, Philip Goulder has been obsessed with a particularly captivating idea: In the hunt for an HIV cure, could children hold the answers? Starting in the mid-2010s, the University of Oxford ...
In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...